Equilis Prequenza

RSS

vaccine against equine influenza in horses

Authorised
This medicine is authorised for use in the European Union.

Overview

This document is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided led to the recommendations on the conditions of use.

This document cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 23/05/2013

Authorisation details

Product details
Name
Equilis Prequenza
Agency product number
EMEA/V/C/000094
Active substance
equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93
International non-proprietary name (INN) or common name
vaccine against equine influenza in horses
Species
Horses
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI05AA01
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
7
Date of issue of marketing authorisation valid throughout the European Union
07/07/2005
Contact address
Intervet International B.V.
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

10/04/2013 Equilis Prequenza - EMEA/V/C/000094 - X/0007/G

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals: Equine influenza vaccine

Therapeutic indication

Active immunisation of horses from six months of age against equine influenza to reduce clinical signs and virus excretion after infection.

Assessment history

How useful was this page?

Add your rating